NOVUSPHARMA (UK) LTD
Get an alert when NOVUSPHARMA (UK) LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-03-31 (in 10mo)
Last filed for 2025-06-30
Confirmation statement due
2027-03-30 (in 10mo)
Last made up 2026-03-16
Watchouts
None on the register
Cash
£724K
-23.3% vs 2024
Net assets
£102K
-75.8% vs 2024
Employees
90
+12.5% highest in 4 filed years
Profit before tax
-£279K
-628.8% vs 2024
Net assets
6-year trend · vs Consumer Discretionary median
Accounts
6-year trend · latest reflected 2025-06-30
| Metric | Trend | 2020-09-30 | 2021-09-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | -£38,273 | -£278,927 | |
| Net profit | — | — | — | — | -£140,811 | -£320,437 | |
| Cash | £15,000 | £234,049 | — | — | £943,327 | £723,817 | |
| Total assets less current liabilities | £10,000 | £2,614,116 | — | — | £5,206,603 | £1,985,202 | |
| Net assets | £10,000 | £408,009 | — | — | £422,664 | £102,227 | |
| Equity | £10,000 | £408,009 | — | — | £422,664 | £102,227 | |
| Average employees | 0 | 58 | — | — | 80 | 90 | |
| Wages | — | — | — | — | £1,732,241 | £1,906,465 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Xeinadin Audit Ltd
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”
Significant events
- “During the year the Company acquired five new pharmacies resulting in increased turnover and improved margins.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 3 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| PATEL, Amar Shilan Kalpesh | Director | 2020-02-13 | Apr 1991 | British |
| PATEL, Kalpesh Kanubhai | Director | 2020-02-13 | Nov 1959 | British |
Show 3 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| PATEL, Chhaya Kalpesh | Director | 2020-02-13 | 2020-02-15 |
| PATEL, Minesh Kanubhai | Director | 2020-02-14 | 2020-02-15 |
| PATEL, Nehul | Director | 2020-02-14 | 2020-02-15 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 33 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-31 | AA | accounts | Accounts with accounts type full | |
| 2026-03-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-31 | AA | accounts | Accounts with accounts type full | |
| 2025-03-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-03-28 | AA | accounts | Accounts with accounts type total exemption full | |
| 2024-03-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-01-09 | OC | miscellaneous | Court order | |
| 2023-09-12 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-07-31 | ANNOTATION | miscellaneous | Legacy | |
| 2023-07-10 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-07-05 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-06-05 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-04-11 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-04-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-03-23 | AA | accounts | Accounts with accounts type total exemption full | |
| 2022-06-28 | AA01 | accounts | Change account reference date company current shortened | |
| 2022-06-15 | AA | accounts | Accounts with accounts type total exemption full | |
| 2022-03-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-08-17 | AA | accounts | Accounts with accounts type total exemption full | |
| 2021-05-19 | AA01 | accounts | Change account reference date company previous shortened |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-06-30 vs 2024-06-30
-
Turnover
—
Not reported
-
Cash
-23.3%
£943,327 £723,817
-
Net assets
-75.8%
£422,664 £102,227
-
Employees
+12.5%
80 90
highest in 4 filed years
-
Profit before tax
-628.8%
-£38,273 -£278,927
-
Wages
+10.1%
£1,732,241 £1,906,465
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers